Published Jul 21, 2015
Beijing, China - Chinese inpatients have experienced overuse of intravenous medications, with a total of 10.4 billion infusion bottles for 1.3 billion Chinese people annually, approximately 8 infusion bottles per capita in 2009. However, few studies have yet been published regarding to the nature of intravenous medication errors in Chinese hospitals. Researchers from Auburn University conducted a direct observational study to examine the current intravenous medication distribution systems in a large teaching hospital in Beijing, China. As described in the article, “Incidence of Intravenous Medication Errors in a Chinese Hospital,“ published in Value in Health Regional Issues Volume 6 focusing on Asia, this study  measured the frequency of intravenous medication errors and identified the clinical importance of errors. The overall intravenous error rate was 12.8% (76 errors out of a total of 593 observed doses). The most frequent error was wrong dose errors (42%), followed by wrong time (29%), omission (21%), unordered dose (5%), and extra dose (3%). Among Total Parenteral Nutrition dose errors, 81% of errors (13 out of 16 errors) were considered having potentially significant clinical consequences. Such errors included insulin, potassium chloride for injection concentrate and sodium chloride for injection concentrate. “It is considered extremely important to ensure quality and safety in the intravenous medication distribution system which involves multiple preparation processes including multiple ingredients. These medications cause immediate onsite effects in the patients,” said the study’s corresponding author, Qian Ding, researcher of medication errors and Assistant Professor at Ferris State University College of Pharmacy. “Such findings of medication errors suggest more aggressive efforts to improve current intravenous medication distribution systems to prevent potential injuries to patients. Results from this study could help develop public health strategies to improve the intravenous medication preparation process and quality of healthcare by reducing medication errors.”

Related Stories

Value in Health Regional Issues Expands Editorial Scope and Reveals Plans to Transition to Gold Open Access Model

Jan 23, 2024

Value in Health Regional Issues, an official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the expansion of its editorial scope and its plan to transition to a gold open access journal.

Empowering Change: Transforming Health Systems in Low- and Middle-Income Countries

Jan 22, 2024

ISPOR announced the publication of a special themed section of research papers in Value in Health Regional Issues that highlight innovative approaches to improving health outcomes in low- and middle-income countries through partnerships between health economics researchers and policy makers.

ISPOR’s Value in Health Regional Issues Receives Its First Impact Factor Score

Aug 7, 2023

Value in Health Regional Issues, the regionally focused journal of ISPOR, received its first-ever impact factor score this year. Value in Health, one of the top-ranked journals in the HEOR field, maintained its high ranking on the prestigious list of scholarly journals.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now